BPMC INVESTOR ALERT: Andrews & Springer LLC Investigates Blueprint Medicines Corporation We are investigating Blueprint Medicines Corporation for potential corporate misconduct

Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China -- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China -- -- Collaboration accelerates and expands global development of Blueprint Medicines’...